Patients Company profile ZS Associates ZS Associates is transforming global healthcare by driving toward a connected ecosystem.
Patients Talent across borders: opening doors for refugee pharmacists... The idea of rebuilding your life from scratch, far away from the people, culture, and places you know and love, would be challenging for many people.
Digital Deep Dive: Digital Health 2022 Following an unprecedented year of surging investment interest, the digital health industry is booming.
Patients The story behind the numbers: how burden of illness studies ... In a time of increasing cost pressures, limited resource capacity, and heightened demand for new treatments, Health Technology Assessments (HTAs) play a vital role in evaluating whether new
Patients Endometriosis: hidden suffering and disease burden Improving patient outcomes starts by listening to and understanding their needs.
Patients The future of clinical research in neurology must be driven ... Strong patient partnerships are more important than ever.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.